Chantal Donovan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chantal Donovan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- James Esposito
Department of Medicine, The University of Melbourne at St Vincent's Hospital (Melbourne), 41 Victoria Parade, Fitzroy, VIC, 3065, Australia
1 shared publication - Jane Elizabeth Bourke
Monash University
1 shared publication - Jean Ni Cheong
Lung Health Research Centre, Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC 3010, Australia
1 shared publication - Meaghan FitzPatrick
Lung Health Research Centre, Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC 3010, Australia
1 shared publication - Mirjam Simoons
Lung Health Research Centre, Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC 3010, Australia
1 shared publication
Latest Publications
- Open Access
- 12 March 2014
- Published by Springer Nature in Respiratory Research
- Vol. 15 (1) , 29
Rosiglitazone is a superior bronchodilator compared to chloroquine and β-adrenoceptor agonists in mouse lung slices
Current therapy for relieving bronchoconstriction may be ineffective in severe asthma, particularly in the small airways. The aim of this study was to further characterise responses to the recently identified novel bronchodilators rosiglitazone (RGZ) and chloroquine (CQ) under conditions where β-adrenoceptor agonist efficacy was limited or impaired in mouse small airways within lung slices.
- 12 March 2014
- Published by Springer Nature in Respiratory Research
- Vol. 15 (1) , 29
Open AccessRosiglitazone is a superior bronchodilator compared to chloroquine and β-adrenoceptor agonists in mouse lung slices
Current therapy for relieving bronchoconstriction may be ineffective in severe asthma, particularly in the small airways. The aim of this study was to further characterise responses to the recently identified novel bronchodilators rosiglitazone (RGZ) and chloroquine (CQ) under conditions where β-adrenoceptor agonist efficacy was limited or impaired in mouse small airways within lung slices.